Caxton Associates (New York)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-20,659
Closed -$562K 673
2020
Q1
$562K Buy
+20,659
New +$562K 0.1% 127